Berobenatide for dyspnea

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Oct 2026: Trial registered, NCT07881757
  2. 19 Oct 2026: Trial started, NCT07881757

The trials

NCT07881757: A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)

State
Under way
Phase
Phase 3
People
258 planned
Started
19 Oct 2026
Primary completion
1 Jun 2028
Arms
Berobenatide
Results
None posted
  1. 19 Oct 2026: Trial registered
  2. 19 Oct 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.